FDA to Speed Review of Generic Drug Applications Until It’s Approved Three of Them image

STAT News, June 27, 2017
Rebecca Robins, quoting Rachel E. Sachs (Academic Fellow Alumna)

Links

Read the Full Article

From the article:

The Food and Drug Administration on Tuesday moved to try to spur more competition in the market for generic drugs, an effort aimed at driving down prices.

In a policy change, the agency will now fast-track applications for generic drugs until three of them have been approved for a given medication. And in a broadcast to manufacturers about what it’s looking for, the FDA also published a list of about 170 categories of old drugs without generics, ranging from a glaucoma drug to the penicillin antibiotic amoxicillin.

Read the full article here.

bioethics fda health law policy pharmaceuticals public health rachel sachs regulation